- PDX were established subcutaneously using samples from patients with primary tumor that metastases to the brain (tissue, cerebrospinal fluid, etc.), whereas cell populations were generated using technology of conditional reprogramming, which can be further labeled with luciferase. These cells can be inoculated into mice ventricle via stereotaxic apparatus. Survival of mice can be recorded and intensity of fluorescence can be tracked timely using In Vivo Imaging System (IVIS).
- LIDE has established over 20 hematological malignancy PDOXs including AML, ALL, multiple myeloma, and different kinds of lymphoma.
Model ID Source CRCs Luciferase labeling In vivo evaluation GL261 Murine glioblastoma cancer cell line N/A N/A Completed U87-MG Human glioblastoma cancer cell line N/A Completed Completed U251 Human glioblastoma cancer cell line N/A Completed TBD LD1-0020-200615 Human glioblastoma PDX Completed Completed Completed LD1-2009-362263 Human breast cancer brain metastasis Completed Completed Completed LD1-2009-362541 Human breast cancer brain metastasis Completed Completed Completed LD1-2017-362457 Human gastric cancer brain metastasis TBD TBD TBD LD1-0011-362257 Human HCC brain metastatic PDX TBD TBD TBD LD1-2059-362445 Human NSCLC brain metastatic PDX TBD TBD TBD